Light-activated treatment for recurring brain tumor
Part of Cancer clinical trials.
This study tests a light-activated therapy (radiodynamic therapy) using a special medicine to help treat a brain tumor that has come back after prior treatment. It may be offered after doctors decide you need further radiation for your recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and your brain tumor is a first recurrence of glioblastoma after prior surgery and treatment
- Your doctors plan more radiation for the tumor recurrence, based on a tumor board decision
- There is confirmed lab proof the tumor is recurrent glioblastoma from a tissue sample, regardless of a specific gene marker
- You can do follow-up scans (MRI, PET, or contrast CT) and you must not be pregnant or breastfeeding
- Your overall strength is good enough (Karnofsky score 60 or higher)
- You can meet safety rules for contraception and avoid certain light-sensitizing medicines before treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach that uses a light-sensitive drug and low-intensity ultrasound to make standard chemotherapy more effective for glioblastoma. If you have completed initial treatment with radiation and temozolomide without the tumor growing, you may be eligible.
This trial studies a two-step treatment for newly diagnosed high-grade glioma: first laser treatment (LITT) to target the tumor, followed by a shorter, more focused course of radiation. It may help shrink or control the tumor while limiting treatment time.
This study looks at how your immune system reacts to brain tumor surgery and standard treatment, using a special dye to help the surgeon see the tumor better. It aims to find out if this approach can improve outcomes for people with glioblastoma.
This trial tests a special form of radiation therapy for older or frail adults with a type of brain tumor called glioma. The radiation is placed directly in the area where the tumor was removed during surgery, which may help prevent the tumor from growing back.
This trial tests a new light-based treatment that is given alongside standard chemotherapy and radiation for people with a type of brain tumor called 'butterfly glioblastoma'. The goal is to see if adding this therapy can improve outcomes for patients with this challenging condition.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.